Search Results 11-20 of 11605 for ���������������������������:za33���24������ ������������������������ ������

  1. Clinical trials - Oncology (Medical)

    The purpose of this study is to assess the 24-week grade 3/4 keratopathy-free rate of an alternative dose/dosing schedule for belantamab mafodotin in ...

  2. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

    unexplained cough for which an underlying condition has not been determined despite adequate investigation with diagnostic tests and trials of therapy.

  3. Health Topics - Mayo Clinic News Network

    June 24, 2024. Orthopedics/Sports. Mayo Clinic Minute: What is hip preservation? Joel Streed. June 24, 2024. Neurosciences. Can music help someone with ...

  4. Prademagene zamikeracel (topical application route) - Side effects & uses - Mayo Clinic

    Prademagene zamikeracel topical is used to treat wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB). This medicine is to be given only by ...

  5. A Study Evaluating The Safety And Efficacy Of Inhaled AP01 In Participants With Progressive Pulmonary Fibrosis - Mayo Clinic

    Rochester, Minnesota: 24-005197; Scottsdale/Phoenix, Arizona: 24-005197. NCT ID: NCT06329401. Sponsor Protocol Number: AP01. About this study. A randomized ...

  6. 24/7 support - Mayo Clinic

    The Nicotine Dependence Center's eight-day residential treatment program is staffed 24 hours a day. Experienced support staff members are present in the ...

  7. Holter monitor - Mayo Clinic

    24, 2022. AskMayoExpert. Ambulatory heart rhythm monitoring. Mayo Clinic; 2021. Medical review (expert opinion). Mayo Clinic. Dec. 5, 2018. Rajakariar K, et al.

  8. A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2) - Mayo Clinic

    ... 24-hour cough frequency in an enriched population of adults with refractory chronic cough (including unexplained chronic cough) at 24 weeks. Participation ...

  9. Clinical trials - Oncology (Medical)

    The percentage of subjects who can enroll on an A2 CAR T-cell therapy study within approximately 24 months of HLA-A LOH status; Percentage of screened ...

  10. Breast cancer - Doctors and departments - Mayo Clinic

    Analyzing the genetic makeup of breast cancer cells to understand how DNA changes affect response to cancer treatments and personalize treatment options.